NCT06508008 Rapid and Safe Sputum Suction Method Validation
| NCT ID | NCT06508008 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Affiliated Hospital of Nantong University |
| Condition | Sputum |
| Study Type | INTERVENTIONAL |
| Enrollment | 900 participants |
| Start Date | 2024-02-18 |
| Primary Completion | 2024-07-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 900 participants in total. It began in 2024-02-18 with a primary completion date of 2024-07-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
600 comatose patients admitted to the hospital in China from June 2024 to June 2028 were randomly divided into groups A and B. Group A used intermittent negative pressure suction through oral and pharyngeal ventilation, while group B used continuous negative pressure suction through regular oral and nasal suction.
Eligibility Criteria
Inclusion Criteria: * 1\. Clinical diagnosis of stroke; 2. Clinical diagnosis of comatose; Exclusion Criteria: * 1\. Clinical diagnosis of multiple organ failure; 2. Clinical diagnosis of multiple organ bleeding;
Contact & Investigator
Tao Zhang, MD
STUDY CHAIR
Ethics Committee of Nantong University Affiliated Hospital
Frequently Asked Questions
Who can join the NCT06508008 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 90 Years, studying Sputum. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06508008 currently recruiting?
Yes, NCT06508008 is actively recruiting participants. Contact the research team at wu_honglei@163.com for enrollment information.
Where is the NCT06508008 trial being conducted?
This trial is being conducted at Nantong, China.
Who is sponsoring the NCT06508008 clinical trial?
NCT06508008 is sponsored by Affiliated Hospital of Nantong University. The principal investigator is Tao Zhang, MD at Ethics Committee of Nantong University Affiliated Hospital. The trial plans to enroll 900 participants.